3月5日,和黄医药(00013/HCM)发布公告,宣布黄德伟被委任为公司独立非执行董事及审计委员会成员,自2025年3月6日起生效。黄德伟在会计、审计及企业财务领域拥有超过35年的丰富经验,曾在多个并购交易中发挥重要作用。他在2017年退任罗兵咸永道会计师事务所合伙人后,继续担任万邦投资有限公司的非执行董事。黄德伟的初步任期将在公司下届股东周年大会结束时终止,若未获重选或提前终止,任期将不再延续。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.